Literature DB >> 26922319

Insufficient radiofrequency ablation promotes the growth of non-small cell lung cancer cells through PI3K/Akt/HIF-1α signals.

Jun Wan1, Wei Wu2, Yun Chen1, Ningning Kang1, Renquan Zhang3.   

Abstract

Accelerated progression of residual non-small cell lung cancer (NSCLC) after incomplete radiofrequency ablation (RFA) has frequently been reported. In this study, NSCLC cells A549, CCL-185, and H358 were treated using a water bath at 47°C for 5, 10, 15, 20, and 25 min gradually to establish the sublines A549-H, CCL-185-H, and H358-H, respectively. A549-H, CCL-185-H, and H358-H cells showed a significant increase in proliferation rate when compared with their corresponding parental cellsin vitro The expression of hypoxia-inducible factor-1α (HIF-1α) was obviously upregulated in both A549-H and CCL-185-H cells. Silencing of HIF-1α abolished the insufficient RFA-induced proliferation in A549-H and CCL-185-H cells. Furthermore, insufficient RFA treatment markedly elevated the phosphorylation of ERK1/2 and Akt, but not of p38 MAPK or JNK, in A549-H and CCL-185-H cells. The inhibitor of Akt, LY294002, but not the inhibitor of ERK1/2, PD98059, suppressed the upregulation of HIF-1α and the proliferation of A549-H and CCL-185-H cellsin vitro Thein vivoresults confirmed that insufficient RFA could trigger the tumor growth, upregulate the HIF-1α expression, and activate Akt in A549 xenograft tumors. Our data suggest that insufficient RFA can promote thein vitroandin vivogrowth of NSCLC via upregulating HIF-1α through the PI3K/Akt signals.
© The Author 2016. Published by ABBS Editorial Office in association with Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences.

Entities:  

Keywords:  HIF-1α; NSCLC; PI3K/Akt; insufficient RFA; proliferation

Mesh:

Substances:

Year:  2016        PMID: 26922319      PMCID: PMC4886244          DOI: 10.1093/abbs/gmw005

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  26 in total

1.  Racial differences in the treatment of early-stage lung cancer.

Authors:  P B Bach; L D Cramer; J L Warren; C B Begg
Journal:  N Engl J Med       Date:  1999-10-14       Impact factor: 91.245

Review 2.  Loco-regional treatment of hepatocellular carcinoma.

Authors:  Riccardo Lencioni
Journal:  Hepatology       Date:  2010-08       Impact factor: 17.425

3.  Radiofrequency thermal ablation in the treatment of lung malignancies.

Authors:  Cosmo Gadaleta; Annamaria Catino; Vittorio Mattioli
Journal:  In Vivo       Date:  2006 Nov-Dec       Impact factor: 2.155

Review 4.  A systematic review of radiofrequency ablation for lung tumors.

Authors:  Jacqui C Zhu; Tristan D Yan; David L Morris
Journal:  Ann Surg Oncol       Date:  2008-03-27       Impact factor: 5.344

5.  TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways.

Authors:  Paola Secchiero; Arianna Gonelli; Edvige Carnevale; Daniela Milani; Assunta Pandolfi; Davide Zella; Giorgio Zauli
Journal:  Circulation       Date:  2003-03-31       Impact factor: 29.690

6.  Low temperature of radiofrequency ablation at the target sites can facilitate rapid progression of residual hepatic VX2 carcinoma.

Authors:  Shan Ke; Xue-mei Ding; Jian Kong; Jun Gao; Shao-hong Wang; Yan Cheng; Wen-bing Sun
Journal:  J Transl Med       Date:  2010-07-29       Impact factor: 5.531

Review 7.  Recent agents targeting HIF-1α for cancer therapy.

Authors:  Yaozhong Hu; Jing Liu; He Huang
Journal:  J Cell Biochem       Date:  2013-03       Impact factor: 4.429

8.  Accelerated perinecrotic outgrowth of colorectal liver metastases following radiofrequency ablation is a hypoxia-driven phenomenon.

Authors:  Maarten W Nijkamp; Jarmila D W van der Bilt; Menno T de Bruijn; I Quintus Molenaar; Emile E Voest; Paul J van Diest; Onno Kranenburg; Inne H M Borel Rinkes
Journal:  Ann Surg       Date:  2009-05       Impact factor: 12.969

9.  Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1α/VEGFA.

Authors:  Jian Kong; Jinge Kong; Bing Pan; Shan Ke; Shuying Dong; Xiuli Li; Aimin Zhou; Lemin Zheng; Wen-bing Sun
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

10.  Insufficient radiofrequency ablation promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through Akt and ERK signaling pathways.

Authors:  Shuying Dong; Jian Kong; Fandong Kong; Jinge Kong; Jun Gao; Shan Ke; Shaohong Wang; Xuemei Ding; Wenbing Sun; Lemin Zheng
Journal:  J Transl Med       Date:  2013-10-29       Impact factor: 5.531

View more
  10 in total

Review 1.  Combined locoregional-immunotherapy for liver cancer.

Authors:  Tim F Greten; Michal Mauda-Havakuk; Bernd Heinrich; Firouzeh Korangy; Bradford J Wood
Journal:  J Hepatol       Date:  2019-02-07       Impact factor: 25.083

2.  All-trans retinoic acid (ATRA) inhibits insufficient radiofrequency ablation (IRFA)-induced enrichment of tumor-initiating cells in hepatocellular carcinoma.

Authors:  Song Wang; Jingtao Liu; Hao Wu; Anna Jiang; Kun Zhao; Kun Yan; Wei Wu; Haibo Han; Yanhua Zhang; Wei Yang
Journal:  Chin J Cancer Res       Date:  2021-12-31       Impact factor: 5.087

3.  [Association of Indoor Air Pollution, Single Nucleotide Polymorphism of HIF-1α Gene with Susceptibility to Lung Cancer in Han Population in Fujian Province].

Authors:  Fei He; Qi Qi; Xu Li; Rendong Xiao; Qiuping Xu; Weimin Xiong; Zhiqiang Liu; Lin Cai
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2017-03-20

4.  Modelling of combination therapy using implantable anticancer drug delivery with thermal ablation in solid tumor.

Authors:  Muneer Al-Zu'bi; Ananda Mohan
Journal:  Sci Rep       Date:  2020-11-09       Impact factor: 4.379

5.  Inhibitory effects of salidroside on MCF-7 breast cancer cells in vivo.

Authors:  An-Qi Sun; Xiu-Lian Ju
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

Review 6.  [Current Status and Progress of Thermal Ablation Combined with Immunotherapy for Lung Tumors].

Authors:  Baodong Liu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2022-04-20

7.  Combination therapy using microwave ablation and d-mannose-chelated iron oxide nanoparticles inhibits hepatocellular carcinoma progression.

Authors:  Rui Cui; Luo Wang; Dongyun Zhang; Kun Zhang; Jianping Dou; Linan Dong; Yixuan Zhang; Jiapeng Wu; Longfei Tan; Jie Yu; Ping Liang
Journal:  Acta Pharm Sin B       Date:  2022-05-29       Impact factor: 14.903

8.  Hyperthermia induced HIF-1a expression of lung cancer through AKT and ERK signaling pathways.

Authors:  Jun Wan; Wei Wu
Journal:  J Exp Clin Cancer Res       Date:  2016-07-26

9.  Short-wave enhances mesenchymal stem cell recruitment in fracture healing by increasing HIF-1 in callus.

Authors:  Dongmei Ye; Chen Chen; Qiwen Wang; Qi Zhang; Sha Li; Hongwei Liu
Journal:  Stem Cell Res Ther       Date:  2020-09-07       Impact factor: 6.832

10.  Independent prognostic value of HIF-1α expression in radiofrequency ablation of lung cancer.

Authors:  Jun Wan; Xiean Ling; Zhanpeng Rao; Bin Peng; Guanggui Ding
Journal:  Oncol Lett       Date:  2019-11-21       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.